Evidence map›Paper›PMID 41210963›Full record

ArticleiScience2025

ZO-1/Tjp1 and ZO-2/Tjp2 deletion in retinal pigment epithelium causes progressive retinal degeneration.

Safiah Mohamed Ali, Bhav Harshad Parikh, Queenie Shu Woon Tan, Barbara Hübner, Aleksandra N Kozyrina, Animesh Banerjee, Jie Zhao, Debbie Goh, Hanumakumar Bogireddi, Sia Wey Yeo and 11 more

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Safiah Mohamed AliInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore 138673, Singapore.
Bhav Harshad ParikhInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore 138673, Singapore.
Queenie Shu Woon TanInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore 138673, Singapore.
Barbara HübnerSchool of Biological Sciences, Nanyang Technological University (NTU), Singapore 637551, Singapore.
Aleksandra N KozyrinaInterdisciplinary Centre for Clinical Research, RWTH Aachen University, 52074 Aachen, Germany.
Animesh BanerjeeInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore 138673, Singapore.
Jie ZhaoDivision of Mathematical Sciences, School of Physical and Mathematical Sciences, Nanyang Technological University (NTU), Singapore 637371, Singapore.
Debbie GohDepartment of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore 119228, Singapore.
Hanumakumar BogireddiInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore 138673, Singapore.
Sia Wey YeoSingapore Eye Research Institute (SERI), Singapore 169856, Singapore.
Daniel Soo Lin WongInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore 138673, Singapore.
Jianliang XuInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore 138673, Singapore.
Kim Chi TranInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore 138673, Singapore.
Zengping LiuInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore 138673, Singapore.
Yun-Zheng LeDepartment of Medicine, Cell Biology, and Ophthalmology and Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City OK 73104, USA.
Veluchamy Amutha BarathiDepartment of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore (NUS), Singapore 119228, Singapore.
Kang Hao CheongDivision of Mathematical Sciences, School of Physical and Mathematical Sciences, Nanyang Technological University (NTU), Singapore 637371, Singapore.
Jacopo Di RussoInterdisciplinary Centre for Clinical Research, RWTH Aachen University, 52074 Aachen, Germany.
Alexander LudwigSchool of Biological Sciences, Nanyang Technological University (NTU), Singapore 637551, Singapore.
Walter HunzikerInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore 138673, Singapore.
Xinyi SuInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A∗STAR), Singapore 138673, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tight junction protein-1 and -2 (Tjp1/ZO-1 and Tjp2/ZO-2) function as scaffold proteins within the tight junction complexes of the blood-retinal barrier (BRB). Although the breakdown of the BRB is implicated in retinopathies, the contribution of ZO-1/2 in the pathogenesis of retinopathies is unknown. To understand their role, we generated RPE-specific conditional ZO-1/2 single KOs (T1KO/T2KO) and ZO-1/2 double knockout (DKO) mice. While T1KO and T2KO did not exhibit overt retinal phenotypes, DKO demonstrated a strong retinal phenotype from 1-month post-KO induction. This includes the loss of RPE integrity and retinal thinning. Furthermore, RPE in DKO re-entered the cell cycle with upregulated YAP. At 12 months, we observed severe structural and functional retinal deterioration. In response to laser-induced damage, RPE displayed persistent hyper-proliferation, delayed wound repair, and the up-regulation of YAP. These studies confirmed the critical role of ZO-1/2 in maintaining an intact BRB and revealed a role of ZO-1/2 in wound healing.

Indexed as

Cell biologyModel organism

Identifiers

PMID41210963
PMCPMC12590551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.